首页 › 基金 › ACUTA CAPITAL PARTNERS, LLC › NERV
ACUTA CAPITAL PARTNERS, LLC 对 NERV 的持仓历史
MINERVA NEUROSCIENCES INC · 医疗保健
ACUTA CAPITAL PARTNERS, LLC 在 Q3 2026 的 13F 申报中披露持有 NERV(MINERVA NEUROSCIENCES INC)729,500 股,市值约 US$2.4M,约占其申报组合的 1.93%,在其申报持仓中市值排名第 16 位。 ACUTA CAPITAL PARTNERS, LLC 最近 4 个申报季度中有 4 个季度披露了 NERV 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ACUTA CAPITAL PARTNERS, LLC 对 NERV 的持仓演变
ACUTA CAPITAL PARTNERS, LLC 于 Q4 2025 首次披露 NERV 持仓:709,500 股(约 US$2.9M)。 该持仓在 Q1 2026 达到峰值 709,500 股,市值约 US$4.3M。 在 4 次申报中,ACUTA CAPITAL PARTNERS, LLC 1 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 729,500 股、市值约 US$2.4M,环比增持 20,000 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 709.50K | $2.85M | 新进 |
| Q1 2026 | 709.50K | $4.27M | 持有 |
| Q2 2026 | 709.50K | $3.94M | 持有 |
| Q3 2026 | 729.50K | $2.44M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NERV 与 13F 数据
NERV(MINERVA NEUROSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 NERV,申报仓位最大的包括:Vivo Capital, LLC (US$14.5M), Ally Bridge Group (NY) LLC (US$12.1M), Foresite Capital Management VI LLC (US$11.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NERV 的基金
- Vivo Capital, LLC 4.32M 股 · $14.48M · Q3 2026
- Ally Bridge Group (NY) LLC 2.18M 股 · $12.08M · Q2 2026
- Foresite Capital Management VI LLC 1.99M 股 · $11.02M · Q2 2026
- Logos Global Management LP 3.29M 股 · $11.02M · Q3 2026
- Seven Fleet Capital Management LP 1.00M 股 · $5.56M · Q2 2026
- Spruce Street Capital LP 1.66M 股 · $5.55M · Q3 2026
- Trails Edge Capital Partners, LP 1.42M 股 · $4.75M · Q3 2026
- DV EQUITIES, LLC 754.40K 股 · $4.19M · Q2 2026
更多关于 ACUTA CAPITAL PARTNERS, LLC
常见问题
How long has ACUTA CAPITAL PARTNERS, LLC held NERV?
ACUTA CAPITAL PARTNERS, LLC has disclosed NERV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is ACUTA CAPITAL PARTNERS, LLC's current position in NERV?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 729.50K shares of NERV (MINERVA NEUROSCIENCES INC), valued at $2.44M, representing 1.93% of its reported portfolio and ranking #16.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling NERV?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC increased its position in NERV. The position peaked in Q1 2026 at 709.50K shares.
Which other funds hold NERV?
Other major institutional holders of NERV include Vivo Capital, LLC, Ally Bridge Group (NY) LLC, Foresite Capital Management VI LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.